Form 8-K - Current report:
SEC Accession No. 0001104659-25-052994
Filing Date
2025-05-27
Accepted
2025-05-27 16:18:11
Documents
13
Period of Report
2025-05-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516205d1_8k.htm   iXBRL 8-K 25348
2 EXHIBIT 99.1 tm2516205d1_ex99-1.htm EX-99.1 54880
  Complete submission text file 0001104659-25-052994.txt   259727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ogn-20250527.xsd EX-101.SCH 3008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20250527_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20250527_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2516205d1_8k_htm.xml XML 3684
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 25988698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)